Type 2 Diabetes Research Updates

For Medical Professionals

Depression and impulse control disorders (eating disorders in particular) are independently associated with diagnosis of type 2 diabetes, according to a cross-sectional survey of adults published online ahead of print in Diabetologia.
Patients with both type 2 diabetes and thyroid cancer are more likely to achieve complete remission if they take metformin than if they do not, according to findings from a retrospective study published in the Journal of Clinical Endocrinology and Metabolism.
Managing adolescents with diabetes through the transition to adult care is challenging in terms of both the physical and psychosocial aspects of care.
Researchers have identified mutations in two genes that can cause neonatal diabetes.
The US Food and Drug Administration has approved Farxiga (dapaglifozin) as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes.
Despite recent advances in prevention and treatment of most diabetes-related vision loss, a study in JAMA Ophthalmology shows that less than half of people with diabetic macular edema know about the association between the diabetes and visual impairment.
People with diabetes have a higher rate of cancer compared to the general population, however, new evidence suggests that the type of anti-diabetic agent prescribed may impact this risk among women.
Data from a large cohort study of older patients with diabetes confirm recent treatment recommendations for this population—that focusing on blood pressure and cholesterol goals may be more beneficial than focusing on glycemic targets.
While widely used diabetes medications have similar effects on glucose control regardless of gender, these agents may have different effects on the hearts of men and women.
Study finds that younger and middle-age women with diabetes have similar heart disease risk factors as men—a 4-fold increase compared to women without diabetes. Aggressive screening and treatment urged.
Shared medical appointments are now being used to allow for more comprehensive diabetes care as well as social support, with the latest research showing significant improvements in glycemic control.
In a study involving more than 2,500 people, those with the highest magnesium intake had the lowest risk of developing type 2 diabetes over a 7-year period.
Large study shows no increased risk of myocardial infarction (heart attach), ischemic strokes, and death in over 16,000 patients treated with saxagliptin (Onglyza).
Report stresses individualized meal planning that fits a person's food preferences and lifestyle.
Antidepressants appeared to be associated with an increased risk for diabetes. However, it is unclear whether this is a causal relationship and the magnitude of the effect may be small.
The Endocrine Society and the American Association of Clinical Endocrinologists (AACE) released a list of specific tests or procedures that are commonly ordered but not always necessary in endocrinology.
Use of an outpatient electronic health record at Kaiser Permanente Northern California was associated with significant decreases in emergency department visits and hospitalizations among patients with diabetes.
Fluoroquinolones have been linked to increased risks of dysglycemia in patients with diabetes and peripheral neuropathy in diabetic and non-diabetes patients.